Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Case Study Suggests Use of Targeted Therapy, Surveillance for Germline ALK-Mutant Neuroblastoma
Premium
Two family members with a germline ALK-mutant neuroblastoma both experienced complete response to ALK inhibitors in a case study.
Cell-free DNA assays are changing the way transplant surgeons conduct routine surveillance and steroid weaning.
Scipher Medicine, InnoSign Collaborate on Biomarker Discovery in Immune-Mediated Diseases
The companies will analyze RNA sequencing data from Scipher to identify biomarkers for patient stratification and drug development.
Akoya, Singapore Consortium Collaborate to ID Markers of Response to Checkpoint Inhibitor Therapy
The project will use Akoya's PhenoCode Discovery IO60 Panel to look at matched pairs of immuno-oncology exceptional responders and hyper-progressors.
The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.